- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetic characterization of CK2 inhibitor CX-4945
Authors
Keywords
CK2, CX-4945, Pharmacokinetics, Druggability
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 36, Issue 7, Pages 840-845
Publisher
Springer Nature
Online
2013-03-30
DOI
10.1007/s12272-013-0103-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Druggability of the CK2 inhibitor CX-4945 as an anticancer drug and beyond
- (2012) Jiyeon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Dose-independent pharmacokinetics of a new peroxisome proliferator-activated receptor-γ agonist, KR-62980, in Sprague-Dawley rats and ICR mice
- (2011) Jong-Shik Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer
- (2011) Denis Drygin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacokinetic characterization of decursinol derived fromAngelica gigasNakai in rats
- (2011) Jin Sook Song et al. XENOBIOTICA
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
- (2010) A. Siddiqui-Jain et al. CANCER RESEARCH
- Preclinical Pharmacokinetics of PDE-310, a Novel PDE4 Inhibitor
- (2010) Jin Sook Song et al. Drug Metabolism and Pharmacokinetics
- New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
- (2010) Miriam López-Ramos et al. FASEB JOURNAL
- Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer
- (2010) Fabrice Pierre et al. JOURNAL OF MEDICINAL CHEMISTRY
- Resorufin: a lead for a new protein kinase CK2 inhibitor
- (2009) Iben Skjøth Sandholt et al. ANTI-CANCER DRUGS
- Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
- (2009) Maria Ruzzene et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
- (2009) Ming-Szu Hung et al. BMC CANCER
- The selectivity of inhibitors of protein kinase CK2: an update
- (2008) Mario A. Pagano et al. BIOCHEMICAL JOURNAL
- Protein Kinase CK2 in Human Diseases
- (2008) Barbara Guerra et al. CURRENT MEDICINAL CHEMISTRY
- Protein kinase CK2 as a druggable target
- (2008) Stefania Sarno et al. Molecular BioSystems
- Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
- (2007) James S. Duncan et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Pharmacokinetics in Drug Discovery
- (2007) Ana Ruiz-Garcia et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole
- (2002) Roberto Battistutta et al. PROTEIN SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now